Share Price and Basic Stock Data
Last Updated: November 6, 2025, 8:36 am
| PEG Ratio | 4.03 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
CCL Products (India) Ltd operates in the Plantations sector, focusing on tea and coffee, with a market capitalization of ₹11,359 Cr. The company has shown a robust growth trajectory, with reported sales increasing from ₹1,462 Cr in FY 2022 to ₹2,071 Cr in FY 2023, and further rising to ₹2,654 Cr in FY 2024. In the trailing twelve months (TTM), sales stood at ₹3,388 Cr, indicating a strong upward trend. Quarterly sales figures for the fiscal year ending March 2025 reveal consistent growth, with revenues rising from ₹727 Cr in Mar 2024 to ₹1,056 Cr in Jun 2025. This growth reflects an increasing demand for CCL’s products, likely driven by its strategic positioning in the coffee and tea markets, which are witnessing rising consumer preferences as seen in various industry reports. The company’s operational efficiency is evident with an operating profit margin (OPM) averaging 19% over the last fiscal year, although it has fluctuated in quarterly reports. Overall, the company demonstrates a solid capacity to capitalize on market opportunities.
Profitability and Efficiency Metrics
CCL Products has reported commendable profitability metrics, with a net profit of ₹310 Cr for FY 2025, up from ₹284 Cr in FY 2023. The earnings per share (EPS) for FY 2025 stood at ₹23.31, showcasing a significant increase from ₹21.35 in FY 2023. The company’s return on equity (ROE) is at a healthy 17%, while the return on capital employed (ROCE) is reported at 13.1%. Operating profit margins, although fluctuating, recorded a high of 22% in Mar 2023 before settling at 18% in FY 2025. The interest coverage ratio (ICR) is robust at 4.99x, indicating the company’s strong ability to meet interest obligations, crucial given the rising borrowings that reached ₹1,815 Cr in FY 2025. This combination of profitability and efficiency metrics positions CCL Products favorably against industry standards, which typically hover around 12-15% for ROE and 10-12% for ROCE, reinforcing its operational effectiveness in a competitive market.
Balance Sheet Strength and Financial Ratios
The balance sheet of CCL Products reflects a solid financial foundation, with total assets amounting to ₹4,241 Cr and total liabilities at ₹4,241 Cr, leading to a manageable debt-to-equity ratio of 0.92x. This indicates that the company is leveraging debt prudently to fuel growth. Reserves have increased significantly, reaching ₹1,941 Cr in FY 2025, up from ₹1,471 Cr in FY 2023, underscoring a strong retained earnings strategy. The current ratio stands at 1.28x, suggesting adequate liquidity to meet short-term obligations, while the quick ratio is at 0.63x, indicating some reliance on inventory for liquidity. CCL’s interest coverage ratio of 4.99x further affirms its ability to service debt comfortably. The company’s price-to-book value ratio of 3.77x suggests a premium valuation in the market, reflecting investor confidence in its growth prospects. Overall, the financial ratios indicate a well-capitalized firm with a balanced approach to growth and risk management.
Shareholding Pattern and Investor Confidence
CCL Products’ shareholding pattern reveals a diverse investor base, with promoters holding 46.09% of the equity as of Mar 2025, consistent with previous quarters. Foreign Institutional Investors (FIIs) have increased their stake to 10.64%, up from 7.56% in Sep 2022, indicating growing confidence among international investors. Domestic Institutional Investors (DIIs) hold 21.19%, while the public holds 21.80%, reflecting a well-distributed ownership structure. The number of shareholders has risen to 54,988, suggesting increasing retail interest in the company. However, the declining public shareholding from 24.32% in Sep 2022 to 21.80% in Mar 2025 may indicate a consolidation of shares among institutional investors, which can be seen as a positive signal of confidence in long-term growth. The stable promoter holding coupled with increasing institutional interest underscores a strong alignment of interests among key stakeholders, which is essential for sustained growth and shareholder value creation.
Outlook, Risks, and Final Insight
Looking ahead, CCL Products is poised for continued growth, driven by its expanding revenue base and strong profitability metrics. However, the company faces risks including rising raw material costs and potential fluctuations in demand for coffee and tea due to changing consumer preferences. The increased borrowings, which stood at ₹1,815 Cr, could also pose a risk if interest rates rise, impacting profitability. Additionally, the company’s reliance on exports exposes it to foreign exchange risks. Nonetheless, its robust operational efficiency and solid financial metrics provide a buffer against these challenges. The positive trends in sales and profitability, combined with a strong balance sheet, position CCL Products favorably against sector norms. Should the company successfully navigate these risks, it can leverage its strengths to enhance shareholder value and market position, making it a compelling player in the tea and coffee industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CCL Products (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 406 Cr. | 188 | 357/162 | 72.8 | 125 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| Diana Tea Company Ltd | 44.9 Cr. | 30.0 | 43.8/26.0 | 43.0 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 117 Cr. | 130 | 190/126 | 98.5 | 213 | 1.15 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 5.47 Cr. | 8.64 | 8.64/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 127 Cr. | 410 | 689/0.00 | 13.7 | 455 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 9,538.75 Cr | 403.82 | 126.82 | 243.96 | 0.41% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 509 | 507 | 535 | 520 | 655 | 608 | 664 | 727 | 773 | 738 | 758 | 836 | 1,056 |
| Expenses | 421 | 409 | 435 | 407 | 549 | 498 | 554 | 609 | 643 | 601 | 634 | 673 | 897 |
| Operating Profit | 89 | 98 | 101 | 113 | 106 | 110 | 111 | 118 | 130 | 137 | 124 | 163 | 159 |
| OPM % | 17% | 19% | 19% | 22% | 16% | 18% | 17% | 16% | 17% | 19% | 16% | 20% | 15% |
| Other Income | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 4 | 1 | 1 | 3 | 4 | 2 |
| Interest | 5 | 7 | 11 | 11 | 15 | 18 | 23 | 21 | 21 | 27 | 31 | 34 | 34 |
| Depreciation | 17 | 17 | 19 | 10 | 22 | 23 | 22 | 31 | 23 | 24 | 25 | 27 | 34 |
| Profit before tax | 67 | 73 | 71 | 95 | 69 | 70 | 67 | 70 | 87 | 87 | 72 | 106 | 94 |
| Tax % | 21% | 21% | -4% | 10% | 13% | 13% | 5% | 7% | 18% | 15% | 12% | 4% | 23% |
| Net Profit | 53 | 58 | 73 | 85 | 61 | 61 | 63 | 65 | 71 | 74 | 63 | 102 | 72 |
| EPS in Rs | 3.96 | 4.34 | 5.49 | 6.41 | 4.56 | 4.57 | 4.76 | 4.88 | 5.35 | 5.54 | 4.72 | 7.63 | 5.43 |
Last Updated: August 20, 2025, 12:25 pm
Below is a detailed analysis of the quarterly data for CCL Products (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,056.00 Cr.. The value appears strong and on an upward trend. It has increased from 836.00 Cr. (Mar 2025) to 1,056.00 Cr., marking an increase of 220.00 Cr..
- For Expenses, as of Jun 2025, the value is 897.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 673.00 Cr. (Mar 2025) to 897.00 Cr., marking an increase of 224.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 159.00 Cr.. The value appears to be declining and may need further review. It has decreased from 163.00 Cr. (Mar 2025) to 159.00 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Mar 2025) to 15.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 34.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 34.00 Cr..
- For Depreciation, as of Jun 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.00 Cr. (Mar 2025) to 34.00 Cr., marking an increase of 7.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 106.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 12.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 4.00% (Mar 2025) to 23.00%, marking an increase of 19.00%.
- For Net Profit, as of Jun 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 102.00 Cr. (Mar 2025) to 72.00 Cr., marking a decrease of 30.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.43. The value appears to be declining and may need further review. It has decreased from 7.63 (Mar 2025) to 5.43, marking a decrease of 2.20.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:32 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 717 | 881 | 932 | 976 | 1,138 | 1,081 | 1,139 | 1,242 | 1,462 | 2,071 | 2,654 | 3,106 | 3,388 |
| Expenses | 574 | 709 | 727 | 744 | 899 | 836 | 853 | 945 | 1,131 | 1,671 | 2,208 | 2,551 | 2,804 |
| Operating Profit | 143 | 171 | 205 | 232 | 239 | 245 | 286 | 298 | 331 | 400 | 445 | 555 | 584 |
| OPM % | 20% | 19% | 22% | 24% | 21% | 23% | 25% | 24% | 23% | 19% | 17% | 18% | 17% |
| Other Income | 3 | 3 | 1 | 1 | 5 | 3 | 4 | 3 | 4 | 3 | 6 | 8 | 10 |
| Interest | 17 | 14 | 11 | 11 | 8 | 8 | 18 | 17 | 16 | 34 | 78 | 113 | 125 |
| Depreciation | 29 | 27 | 28 | 33 | 34 | 32 | 47 | 49 | 57 | 64 | 98 | 98 | 109 |
| Profit before tax | 100 | 134 | 167 | 189 | 202 | 209 | 225 | 235 | 261 | 305 | 276 | 352 | 359 |
| Tax % | 35% | 30% | 27% | 29% | 27% | 26% | 26% | 22% | 22% | 7% | 9% | 12% | |
| Net Profit | 64 | 94 | 122 | 135 | 148 | 155 | 166 | 182 | 204 | 284 | 250 | 310 | 311 |
| EPS in Rs | 4.84 | 7.06 | 9.18 | 10.12 | 11.14 | 11.64 | 12.47 | 13.70 | 15.36 | 21.35 | 18.73 | 23.24 | 23.32 |
| Dividend Payout % | 25% | 21% | 27% | 25% | 22% | 30% | 40% | 29% | 33% | 21% | 24% | 22% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 46.88% | 29.79% | 10.66% | 9.63% | 4.73% | 7.10% | 9.64% | 12.09% | 39.22% | -11.97% | 24.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -17.09% | -19.13% | -1.03% | -4.90% | 2.37% | 2.54% | 2.45% | 27.13% | -51.19% | 35.97% |
CCL Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 22% |
| 3 Years: | 29% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 15% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 23% |
| 1 Year: | 11% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:40 am
Balance Sheet
Last Updated: May 13, 2025, 3:43 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 326 | 395 | 483 | 602 | 713 | 812 | 902 | 1,061 | 1,224 | 1,471 | 1,647 | 1,941 |
| Borrowings | 292 | 229 | 210 | 142 | 311 | 416 | 469 | 559 | 655 | 920 | 1,622 | 1,815 |
| Other Liabilities | 80 | 111 | 81 | 78 | 83 | 166 | 112 | 142 | 164 | 180 | 240 | 459 |
| Total Liabilities | 725 | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 |
| Fixed Assets | 361 | 340 | 417 | 393 | 371 | 383 | 724 | 798 | 882 | 1,257 | 1,252 | 1,622 |
| CWIP | 39 | 53 | 0 | 0 | 226 | 424 | 100 | 149 | 160 | 54 | 501 | 450 |
| Investments | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 324 | 367 | 382 | 453 | 535 | 613 | 684 | 841 | 1,028 | 1,286 | 1,783 | 2,169 |
| Total Assets | 725 | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 |
Below is a detailed analysis of the balance sheet data for CCL Products (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,941.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,647.00 Cr. (Mar 2024) to 1,941.00 Cr., marking an increase of 294.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1,815.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,622.00 Cr. (Mar 2024) to 1,815.00 Cr., marking an increase of 193.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 459.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 240.00 Cr. (Mar 2024) to 459.00 Cr., marking an increase of 219.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 4,241.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,536.00 Cr. (Mar 2024) to 4,241.00 Cr., marking an increase of 705.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,622.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,252.00 Cr. (Mar 2024) to 1,622.00 Cr., marking an increase of 370.00 Cr..
- For CWIP, as of Mar 2025, the value is 450.00 Cr.. The value appears to be declining and may need further review. It has decreased from 501.00 Cr. (Mar 2024) to 450.00 Cr., marking a decrease of 51.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,169.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,783.00 Cr. (Mar 2024) to 2,169.00 Cr., marking an increase of 386.00 Cr..
- For Total Assets, as of Mar 2025, the value is 4,241.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,536.00 Cr. (Mar 2024) to 4,241.00 Cr., marking an increase of 705.00 Cr..
Notably, the Reserves (1,941.00 Cr.) exceed the Borrowings (1,815.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -149.00 | -58.00 | -5.00 | 90.00 | -72.00 | -171.00 | -183.00 | -261.00 | -324.00 | -520.00 | 444.00 | 554.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 50 | 61 | 58 | 79 | 86 | 88 | 80 | 78 | 68 | 81 |
| Inventory Days | 118 | 116 | 99 | 121 | 97 | 123 | 170 | 198 | 262 | 187 | 185 | 208 |
| Days Payable | 18 | 29 | 8 | 8 | 5 | 35 | 16 | 13 | 23 | 24 | 23 | 44 |
| Cash Conversion Cycle | 155 | 134 | 142 | 174 | 150 | 168 | 240 | 272 | 319 | 241 | 230 | 246 |
| Working Capital Days | 36 | 45 | 37 | 81 | 89 | 43 | 103 | 59 | 77 | 58 | 40 | 42 |
| ROCE % | 19% | 23% | 26% | 27% | 23% | 19% | 18% | 17% | 16% | 16% | 12% | 13% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Magnum Global Fund | 4,400,000 | 4.32 | 297 | 4,400,000 | 2025-04-22 15:56:59 | 0% |
| Canara Robeco ELSS Tax Saver Fund | 1,041,623 | 0.79 | 70.31 | 1,041,623 | 2025-04-22 15:56:59 | 0% |
| Canara Robeco Small Cap Fund | 487,897 | 0.27 | 32.93 | 487,897 | 2025-04-22 15:56:59 | 0% |
| SBI Magnum Comma Fund | 425,000 | 4.34 | 28.69 | 425,000 | 2025-04-22 15:56:59 | 0% |
| LIC MF Flexi Cap Fund | 194,778 | 1.18 | 13.15 | 194,778 | 2025-04-22 17:25:39 | 0% |
| Axis Capital Builder Fund - Series 4 | 223,401 | 0.92 | 12.68 | 223,401 | 2025-04-22 09:59:38 | 0% |
| LIC MF ELSS Tax Saver Fund | 181,585 | 1.03 | 12.26 | 181,585 | 2025-04-22 15:56:59 | 0% |
| Canara Robeco Value Fund | 180,000 | 0.94 | 12.15 | 180,000 | 2025-04-22 17:25:39 | 0% |
| LIC MF Multi Cap Fund | 169,862 | 0.89 | 11.47 | 169,862 | 2025-04-22 16:12:48 | 0% |
| HSBC Small Cap Equity Fund - OLD | 150,000 | 2.5 | 7.51 | 150,000 | 2025-04-22 15:56:59 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 23.31 | 18.80 | 20.21 | 15.36 | 13.70 |
| Diluted EPS (Rs.) | 23.26 | 18.76 | 20.21 | 15.36 | 13.70 |
| Cash EPS (Rs.) | 30.61 | 26.14 | 25.00 | 19.68 | 17.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 147.33 | 125.82 | 111.42 | 94.02 | 81.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 147.33 | 125.82 | 111.42 | 94.02 | 81.73 |
| Revenue From Operations / Share (Rs.) | 232.59 | 199.48 | 155.70 | 109.90 | 93.40 |
| PBDIT / Share (Rs.) | 42.20 | 33.95 | 30.30 | 25.19 | 22.64 |
| PBIT / Share (Rs.) | 34.83 | 26.61 | 25.51 | 20.87 | 18.92 |
| PBT / Share (Rs.) | 26.38 | 20.77 | 22.93 | 19.65 | 17.65 |
| Net Profit / Share (Rs.) | 23.24 | 18.80 | 20.21 | 15.36 | 13.70 |
| NP After MI And SOA / Share (Rs.) | 23.24 | 18.80 | 20.21 | 15.36 | 13.70 |
| PBDIT Margin (%) | 18.14 | 17.01 | 19.46 | 22.92 | 24.23 |
| PBIT Margin (%) | 14.97 | 13.33 | 16.38 | 18.99 | 20.26 |
| PBT Margin (%) | 11.34 | 10.40 | 14.72 | 17.87 | 18.89 |
| Net Profit Margin (%) | 9.99 | 9.42 | 12.98 | 13.97 | 14.66 |
| NP After MI And SOA Margin (%) | 9.99 | 9.42 | 12.98 | 13.97 | 14.66 |
| Return on Networth / Equity (%) | 15.77 | 14.94 | 18.14 | 16.33 | 16.76 |
| Return on Capital Employeed (%) | 17.85 | 15.67 | 19.27 | 19.28 | 19.07 |
| Return On Assets (%) | 7.31 | 7.07 | 10.35 | 9.87 | 10.19 |
| Long Term Debt / Equity (X) | 0.28 | 0.30 | 0.13 | 0.08 | 0.16 |
| Total Debt / Equity (X) | 0.92 | 0.96 | 0.61 | 0.44 | 0.43 |
| Asset Turnover Ratio (%) | 0.79 | 0.86 | 0.68 | 0.54 | 0.53 |
| Current Ratio (X) | 1.28 | 1.36 | 1.49 | 1.57 | 1.69 |
| Quick Ratio (X) | 0.63 | 0.74 | 0.79 | 0.74 | 1.01 |
| Inventory Turnover Ratio (X) | 3.37 | 2.38 | 1.57 | 1.35 | 1.35 |
| Dividend Payout Ratio (NP) (%) | 8.60 | 26.59 | 24.73 | 32.54 | 14.59 |
| Dividend Payout Ratio (CP) (%) | 6.53 | 19.12 | 19.99 | 25.40 | 11.48 |
| Earning Retention Ratio (%) | 91.40 | 73.41 | 75.27 | 67.46 | 85.41 |
| Cash Earning Retention Ratio (%) | 93.47 | 80.88 | 80.01 | 74.60 | 88.52 |
| Interest Coverage Ratio (X) | 4.99 | 5.81 | 11.72 | 20.49 | 17.76 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 4.22 | 8.82 | 13.49 | 11.75 |
| Enterprise Value (Cr.) | 9123.03 | 9248.47 | 8386.00 | 5873.65 | 3469.07 |
| EV / Net Operating Revenue (X) | 2.94 | 3.49 | 4.05 | 4.02 | 2.79 |
| EV / EBITDA (X) | 16.19 | 20.48 | 20.80 | 17.53 | 11.52 |
| MarketCap / Net Operating Revenue (X) | 2.39 | 2.94 | 3.65 | 3.67 | 2.51 |
| Retention Ratios (%) | 91.39 | 73.40 | 75.26 | 67.45 | 85.40 |
| Price / BV (X) | 3.77 | 4.66 | 5.10 | 4.29 | 2.86 |
| Price / Net Operating Revenue (X) | 2.39 | 2.94 | 3.65 | 3.67 | 2.51 |
| EarningsYield | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 |
After reviewing the key financial ratios for CCL Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.31. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 23.31, marking an increase of 4.51.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.26. This value is within the healthy range. It has increased from 18.76 (Mar 24) to 23.26, marking an increase of 4.50.
- For Cash EPS (Rs.), as of Mar 25, the value is 30.61. This value is within the healthy range. It has increased from 26.14 (Mar 24) to 30.61, marking an increase of 4.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 147.33. It has increased from 125.82 (Mar 24) to 147.33, marking an increase of 21.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 147.33. It has increased from 125.82 (Mar 24) to 147.33, marking an increase of 21.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 232.59. It has increased from 199.48 (Mar 24) to 232.59, marking an increase of 33.11.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 42.20. This value is within the healthy range. It has increased from 33.95 (Mar 24) to 42.20, marking an increase of 8.25.
- For PBIT / Share (Rs.), as of Mar 25, the value is 34.83. This value is within the healthy range. It has increased from 26.61 (Mar 24) to 34.83, marking an increase of 8.22.
- For PBT / Share (Rs.), as of Mar 25, the value is 26.38. This value is within the healthy range. It has increased from 20.77 (Mar 24) to 26.38, marking an increase of 5.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.24. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 23.24, marking an increase of 4.44.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.24. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 23.24, marking an increase of 4.44.
- For PBDIT Margin (%), as of Mar 25, the value is 18.14. This value is within the healthy range. It has increased from 17.01 (Mar 24) to 18.14, marking an increase of 1.13.
- For PBIT Margin (%), as of Mar 25, the value is 14.97. This value is within the healthy range. It has increased from 13.33 (Mar 24) to 14.97, marking an increase of 1.64.
- For PBT Margin (%), as of Mar 25, the value is 11.34. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 11.34, marking an increase of 0.94.
- For Net Profit Margin (%), as of Mar 25, the value is 9.99. This value is within the healthy range. It has increased from 9.42 (Mar 24) to 9.99, marking an increase of 0.57.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.99. This value is within the healthy range. It has increased from 9.42 (Mar 24) to 9.99, marking an increase of 0.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.77. This value is within the healthy range. It has increased from 14.94 (Mar 24) to 15.77, marking an increase of 0.83.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.85. This value is within the healthy range. It has increased from 15.67 (Mar 24) to 17.85, marking an increase of 2.18.
- For Return On Assets (%), as of Mar 25, the value is 7.31. This value is within the healthy range. It has increased from 7.07 (Mar 24) to 7.31, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.28. This value is within the healthy range. It has decreased from 0.30 (Mar 24) to 0.28, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.92. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.92, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.86 (Mar 24) to 0.79, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 1.36 (Mar 24) to 1.28, marking a decrease of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.74 (Mar 24) to 0.63, marking a decrease of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.37. This value is below the healthy minimum of 4. It has increased from 2.38 (Mar 24) to 3.37, marking an increase of 0.99.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.60. This value is below the healthy minimum of 20. It has decreased from 26.59 (Mar 24) to 8.60, marking a decrease of 17.99.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.53. This value is below the healthy minimum of 20. It has decreased from 19.12 (Mar 24) to 6.53, marking a decrease of 12.59.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.40. This value exceeds the healthy maximum of 70. It has increased from 73.41 (Mar 24) to 91.40, marking an increase of 17.99.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.47. This value exceeds the healthy maximum of 70. It has increased from 80.88 (Mar 24) to 93.47, marking an increase of 12.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.99. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 4.99, marking a decrease of 0.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 4.22 (Mar 24) to 3.75, marking a decrease of 0.47.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,123.03. It has decreased from 9,248.47 (Mar 24) to 9,123.03, marking a decrease of 125.44.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has decreased from 3.49 (Mar 24) to 2.94, marking a decrease of 0.55.
- For EV / EBITDA (X), as of Mar 25, the value is 16.19. This value exceeds the healthy maximum of 15. It has decreased from 20.48 (Mar 24) to 16.19, marking a decrease of 4.29.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 2.94 (Mar 24) to 2.39, marking a decrease of 0.55.
- For Retention Ratios (%), as of Mar 25, the value is 91.39. This value exceeds the healthy maximum of 70. It has increased from 73.40 (Mar 24) to 91.39, marking an increase of 17.99.
- For Price / BV (X), as of Mar 25, the value is 3.77. This value exceeds the healthy maximum of 3. It has decreased from 4.66 (Mar 24) to 3.77, marking a decrease of 0.89.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 2.94 (Mar 24) to 2.39, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CCL Products (India) Ltd:
- Net Profit Margin: 9.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.85% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.77% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 35.1 (Industry average Stock P/E: 126.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.92
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Duggirala, Guntur District Andhra Pradesh 522330 | info@continental.coffee http://www.cclproducts.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Challa Rajendra Prasad | Executive Chairman |
| Mr. Challa Srishant | Managing Director |
| Mr. B Mohan Krishna | Executive Director |
| Ms. Challa Shantha Prasad | Non Executive Director |
| Mr. Satyavada Venkata Ramachandra Rao | Non Executive Director |
| Mr. K V Chowdary | Independent Director |
| Mr. Durga Prasad Kode | Independent Director |
| Mrs. Kulsoom Noor Saifullah | Independent Director |
| Dr. Krishnanand Lanka | Independent Director |
| Mr. Sudhakar Ambati | Independent Director |
FAQ
What is the intrinsic value of CCL Products (India) Ltd?
CCL Products (India) Ltd's intrinsic value (as of 06 November 2025) is 748.85 which is 15.76% lower the current market price of 889.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 11,866 Cr. market cap, FY2025-2026 high/low of 969/475, reserves of ₹1,941 Cr, and liabilities of 4,241 Cr.
What is the Market Cap of CCL Products (India) Ltd?
The Market Cap of CCL Products (India) Ltd is 11,866 Cr..
What is the current Stock Price of CCL Products (India) Ltd as on 06 November 2025?
The current stock price of CCL Products (India) Ltd as on 06 November 2025 is 889.
What is the High / Low of CCL Products (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CCL Products (India) Ltd stocks is 969/475.
What is the Stock P/E of CCL Products (India) Ltd?
The Stock P/E of CCL Products (India) Ltd is 35.1.
What is the Book Value of CCL Products (India) Ltd?
The Book Value of CCL Products (India) Ltd is 156.
What is the Dividend Yield of CCL Products (India) Ltd?
The Dividend Yield of CCL Products (India) Ltd is 0.56 %.
What is the ROCE of CCL Products (India) Ltd?
The ROCE of CCL Products (India) Ltd is 13.1 %.
What is the ROE of CCL Products (India) Ltd?
The ROE of CCL Products (India) Ltd is 17.0 %.
What is the Face Value of CCL Products (India) Ltd?
The Face Value of CCL Products (India) Ltd is 2.00.